The trusted source for
healthcare information and
CONTINUING EDUCATION.
Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital
Executive Editor
Leslie Coplin
Managing Editor
Neill Kimball
Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience
Assistant Editors
Padmaja Kandula, MD
Assistant Professor of Neurology and Neuroscience
Comprehensive Epilepsy Center
Weill Cornell Medical College
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders
Authors
Jai S. Perumal, MD
Assistant Professor of Neurology
Weill Cornell Medical College
Joshua Weaver, MD
Clinical Neurophysiology Fellow
Weill Cornell Medical College
Norman Latov, MD, PhD
Professor of Neurology and Neuroscience
Director of the Peripheral Neuropathy Clinical and Research Center
Weill Cornell Medical College
Halinder S. Mangat, MD
Assistant Professor of Clinical Neurology
Weill Cornell Medical College
Sotirios Keros, MD, PhD
Instructor, Department of Pediatrics
Division of Pediatric Neurology
Weill Cornell Medical College
Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Assistant editorsMichael Rubin, MD, FRCP(C), author Joshua Weaver, MD, author Halinder S. Mangat, MD, author Sotirios Keros, MD, PhD, peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study. Author Jai S. Perumal, MD is a consultant for Biogen Idec and Genzyme, and is on the speakers bureau for Teva and Biogen Idec. Author Norman Latov, MD, PhD has served as consultant to Grifols, Novartis, CSL Behring, Pfizer, Octapharma, Sanofi, Baxter Biotherapeutics, Elan Pharmaceuticals, Depomed, and Eisai Inc. He owns stock in Therapath LLC, and is beneficiary of a licensing agreement between Cornell University and Teva Pharmaceuticals for a patent related to the use of MSR1 antibodies in inflammatory diseases.
Copyright 2012 AHC Media LLC. All rights reserved.